Manulife (Manufacturers Life Insurance)’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,913	Closed	-$415K	–	3381
2021 Q1	$415K	Buy	+6,913	New	+$250K	﹤0.01%	2412

Manulife (Manufacturers Life Insurance)'s PAND Position: Q2 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 6,913 shares — an estimated $415K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $415K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Manulife (Manufacturers Life Insurance) reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 6,913 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $415K.
Manulife (Manufacturers Life Insurance) first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Manulife (Manufacturers Life Insurance)'s Pandion Therapeutics Inc. Common Stock position peaked at $415K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.